-+ 0.00%
-+ 0.00%
-+ 0.00%

ALTIMMUNE's pre-market share price rose 17% as its drug reached a major target in the mid-term study of alcohol use disorder.

Zhitongcaijing·07/28/2026 11:17:11
Listen to the news
ALTIMMUNE's pre-market share price rose 17% as its drug reached a major target in the mid-term study of alcohol use disorder.